These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related]
87. Botulinum toxin treatment of spasmodic torticollis. Anderson TJ; Rivest J; Stell R; Steiger MJ; Cohen H; Thompson PD; Marsden CD J R Soc Med; 1992 Sep; 85(9):524-9. PubMed ID: 1433117 [TBL] [Abstract][Full Text] [Related]
88. Self-reported benefit and weakness after botulinum toxin in dystonia. Kassavetis P; Lungu C; Ehrlich D; Alter K; Karp BI Parkinsonism Relat Disord; 2020 Nov; 80():10-11. PubMed ID: 32927341 [TBL] [Abstract][Full Text] [Related]
89. Development of botulinum toxin therapy. Hermanowicz N; Truong DD West J Med; 1995 Nov; 163(5):472-3. PubMed ID: 8533413 [No Abstract] [Full Text] [Related]
90. Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years. Mauriello JA; Aljian J Br J Ophthalmol; 1991 Dec; 75(12):737-9. PubMed ID: 1768664 [TBL] [Abstract][Full Text] [Related]
91. Botulinum toxin therapy for neurologic disorders. Tim R; Massey JM Postgrad Med; 1992 May; 91(6):327-32, 334. PubMed ID: 1579537 [TBL] [Abstract][Full Text] [Related]
92. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Kenney C; Jankovic J J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461 [TBL] [Abstract][Full Text] [Related]
93. The use of botulinum toxin in blepharospasm. Shorr N; Seiff SR; Kopelman J Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489 [TBL] [Abstract][Full Text] [Related]
94. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin. Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963 [TBL] [Abstract][Full Text] [Related]
95. Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings. Comella CL; Tanner CM; DeFoor-Hill L; Smith C Neurology; 1992 Jul; 42(7):1307-10. PubMed ID: 1620339 [TBL] [Abstract][Full Text] [Related]
96. Botulinum A toxin (Oculinum) in ophthalmology. Osako M; Keltner JL Surv Ophthalmol; 1991; 36(1):28-46. PubMed ID: 1925943 [TBL] [Abstract][Full Text] [Related]
97. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up. Moore AP; Blumhardt LD J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):813-6. PubMed ID: 1955900 [TBL] [Abstract][Full Text] [Related]
98. Treatment of blepharospasm with botulinum toxin. Tsoy EA; Buckley EG; Dutton JJ Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122 [TBL] [Abstract][Full Text] [Related]
99. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients. Poewe W; Schelosky L; Kleedorfer B; Heinen F; Wagner M; Deuschl G J Neurol; 1992 Jan; 239(1):21-5. PubMed ID: 1541964 [TBL] [Abstract][Full Text] [Related]
100. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. Valls-Sole J; Tolosa ES; Ribera G J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]